Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Medpace Holdings Community
NasdaqGS:MEDP Community
1
Narratives
written by author
0
Comments
on narratives written by author
65
Fair Values set
on narratives written by author
Create a narrative
Medpace Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Medpace Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Book-to-bill Ratios And RFP Improvements Will Drive Performance
Key Takeaways Improved backlog growth expectations and higher book-to-bill ratios could boost Medpace's revenue and stabilize margins. Effective share repurchase strategies may enhance earnings per share through reduced share count under the current authorization program.
View narrative
US$298.76
FV
6.8% overvalued
intrinsic discount
5.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
MEDP
MEDP
Medpace Holdings
Your Fair Value
US$
Current Price
US$319.16
26.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-14m
3b
2015
2018
2021
2024
2025
2027
2030
Revenue US$2.8b
Earnings US$547.1m
Advanced
Set Fair Value